Profile
Arsenal Capital Partners is a private equity investment firm specializing in the industrial growth and healthcare sectors. Based in the United States, Arsenal is committed to building technology- and innovation-rich companies that are strategically significant to their markets. With a team that combines deep scientific and industrial expertise, Arsenal collaborates closely with management teams to develop dynamic strategies that add substantial market value. Arsenal's approach is characterized by its commitment to high growth and differentiated businesses with enduring value.
The firm invests across sectors such as industrial growth and healthcare, focusing on high-performance value-adding solutions. Arsenal has successfully completed over 320 platform and add-on transactions and raised more than $10 billion in institutional funds. Their investment strategy includes a commitment to unlocking the potential in people and technologies and offering differentiated insights through strategic partnerships. Arsenal's deep domain expertise allows it to identify and leverage high-growth opportunities.
Arsenal's notable portfolio companies include Certara - a technological solution for drug discovery, Lumanity - focusing on emissions reduction in the climate sector, and companies like Velcro Companies, Polycrop, and Certara involved in various strategic business operations across sectors. These investments highlight Arsenal's focus on building market-leading companies with strategic competitive advantages.
Industry
Arsenal Capital Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Arsenal Capital Partners LP
|
Venture Capital (VC)
|
Business Services (B2B)
Financial Services
Fintech
Healthcare Services
Industrial
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$270 M
|
June 2003
|
|
Arsenal Capital Management, LLC
|
Venture Capital (VC)
|
Business Services (B2B)
Financial Services
Fintech
Healthcare Services
Technology
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$2 M
|
April 2013
|
|
Arsenal Capital Fund V
|
Venture Capital (VC)
|
Consumer Products
Financial Services
Fintech
Healthcare Services
Technology
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$2400 M
|
April 2019
|
|
Arsenal Capital Partners VI LP
|
Private Equity (PE)
|
Business Services (B2B)
Financial Services
Fintech
Healthcare Services
Industrial
Technology
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$4300 M
|
August 2022
|
|
Arsenal Capital Fund IV
|
Private Equity (PE)
|
Food and Beverage
Foodtech
Healthcare Services
Real Estate
Transportation
Energy
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1 M
|
October 2016
|
|
Arsenal Capital Partners Growth LP
|
Private Equity (PE)
|
Food and Beverage
Foodtech
Healthcare Services
Real Estate
SaaS
Software
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1 M
|
August 2022
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.